FRANKFURT, Germany, October 25, 2021 /PRNewswire/ – European Wellness Academy (EWA), the educational arm of European Wellness Biomedical Group (EWG), has signed an agreement to carry out joint scientific research on the efficacy of peptides and cell therapy, exosomes and in vivo cell reprogramming for rejuvenation in premature murine aging models in vitro and in vivo.
EWA was earlier represented by its Group Chairman, Prof. Dr. Mike Chan, while Heidelberg University was represented by its Commercial Managing Director, Katrin Erk and its Head of Institute of Anatomy and Cell Biology III, Prof. Dr. Thomas Skutella.
The therapeutics used for the studies are precursor (progenitor) stem cells (PSC), precursor cells (Frozen Organo Crygenics (FOC)), Mito Organelle (MO), Nano Organo Peptides (NOP) and exosomes.
The in vitro experiment of the study concentrates on the effects of the products on the aging of somatic cells in vitro as senescent cells are known to contribute to disease onset and progression through the complex cell and non-cell-autonomous mechanisms. The investigated exosomes include neuronal stem cells (NSCs), mesenchymal stem cells (MSCs), cardiomyocytes, kidney progenitors and hepatocytes.
The subsequent in vivo experiment targets to demonstrate both safety and efficacy of the therapeutics where proof of effectivity are recorded on life span, histopathological and molecular criteria of neurodegeneration including Alzheimer/dementia, and system degeneration disorders including skin, cardio, lung, kidney, liver, stomach/intestine/gut, muscular dystrophy, immune system and eye.
Other criteria included are cartilage/joint/bone regeneration including knees/joints/hips, cervical, thoracic, lumbar, pelvic and musculoskeletal disorder. Endocrine disorders like endocrinal dysfunction due to over and underproduction of hormones and other activity pattern under the sleep wake cycle.
The ongoing specially designed studies was coordinated and designed by Prof. Dr. Thomas Skutella of Heidelberg University, a world-renowned research university and one of Germany’s Top 3, Prof. Dr. Mike Chan and scientists of EWG.
European Wellness Group
Founded in 1991, European Wellness Group is an award-winning European group most renowned for its pioneering developments in precursor stem cell therapeutics, biological peptides, biological regenerative medicine and immunomodulating. The Group’s portfolio comprises multinational business divisions that collectively operates in the emerging fields of biological regenerative medicine; these divisions include research and development, bio-manufacturing, and education, anti-ageing centres and product distribution to practitioners and consumers across 80 countries. The Group also owns a growing network of 26 internationally accredited Wellness Centres globally. Today, the Group is headquartered in Germany and Kota Kinabalu, Malaysia (Asia Pacific) with research and its own manufacturing facilities in Germany, Switzerland, United States, United Kingdom and the European Union.
European Wellness Academy
Located in Germany, Switzerland, Greece and Malaysia, EWA is a UK CPD authorised body with a premium training and development wing that revolves around cutting-edge Bio-Regenerative Medicine modalities for practitioners and researchers. The Academy has extensive years of combined clinical experience and a core academic team comprising of qualified clinicians and scientists with multiple international affiliations and accreditations.
In The News
Follow us on: